Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Gross Profit

Amneal Pharmaceuticals Inc Gross Profit Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Gross Profit from 2016 to 2018. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Amneal Pharmaceuticals Inc Gross Profit for the quarter ending December 12, 2018 was $190m a 21.46% increase of 41m year over year
  • Amneal Pharmaceuticals Inc Gross Profit for the last 12 months ending December 12, 2018 was $700m a 15.59% increase of 109m year over year
  • Amneal Pharmaceuticals Inc Annual Gross Profit for 2018 was $700m a 20.49% increase of 143m from 2017
  • Amneal Pharmaceuticals Inc Annual Gross Profit for 2017 was $557m a -5.99% decrease of -33m from 2016
  • Amneal Pharmaceuticals Inc Annual Gross Profit for 2016 was $590m a 15.39% increase of 91m from 2015
Other Income Statement Metrics:
  • Amneal Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $109m a 21.60% increase of 24m year over year
  • Amneal Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-9m a 687.76% decrease of -60m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Gross Profit Data

12/2018$190m
09/2018$214m
06/2018$174m
03/2018$149m
12/2017$161m
09/2017$128m
06/2017$119m
03/2017$115m
12/2016$177m

Annual AMRX Gross Profit Data

2018$700m
2017$557m
2016$590m
2015$499m
2014$450m